24 Feb Correction: Research and Development Update
This is a correction to the Research and Development Update announcement published at 7:00am on 24 February 2021 (RNS number 1141Q) which has been amended with the following underlined additions...
24 Feb Research and Development Update
Paris, France and Camberley, UK – 24 February 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on the progress of its...
16 Feb SARS-CoV-2 Mutations – Cause for Concern? (Revised 1)
Posted at 09:32h
in Blog
SARS-CoV-2 Mutations – Cause for Concern? The accumulation of genetic mutations is a normal part of viral evolution. Mutations change the sequence of the viral genome, creating different 'variants.' While some...
02 Feb Launch of PCR genotyping assay portfolio to detect COVID-19 variants
Paris, France and Camberley, UK – 2 February 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of a new and innovative...
29 Jan Full Year 2020 Trading Update
Paris, France and Camberley, UK – 29 January 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited trading update for the year...
27 Jan SARS-CoV-2 Mutations – Cause for Concern?
SARS-CoV-2 Mutations – Cause for Concern? The accumulation of genetic mutations is a normal part of viral evolution. Mutations change the sequence of the viral genome, creating different 'variants.' While some...
27 Jan Holdings in Company
Paris, France and Camberley, UK – 26 January 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 26 January...
20 Jan Learn more about COVID-19 antibody testing
Learn more about our range of COVID-19 solutions and how they could help with your diagnostic needs. As we enter 2021, we also move into a new phase of the COVID-19...
13 Jan Holdings in Company
Paris, France and Camberley, UK – 13 January 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 12 January...
05 Jan Executive Management and Proposed Board Changes
Paris, France and Camberley, UK – 5 January 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that James McCarthy has been appointed as...